Fat embolism: Evolution of histopathological changes in the rat lung

Journal of Orthopaedic Research

Volumn 28, Issue 2, 2010, Pages 191-197

  McIff, Terence E ^a   Poisner, Alan M ^a   Herndon, Betty ^b   Lankachandra, Kamani ^b   Schutt, Shane ^a   Haileselassie, Berekeetab ^b   Patel, Sapna ^b   Quinn, Tim ^b   Adler, Federico ^a   Molteni, Agostino ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult respiratory distress syndrome; Fat embolism syndrome; Fibrosis; Inflammation; Triolein

Indexed keywords

COLLAGEN; FAT; SMOOTH MUSCLE ACTIN; TRIOLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAT EMBOLISM; FIBROSIS; HISTOPATHOLOGY; INFERIOR CAVA VEIN; INFLAMMATION; LUNG; LUNG LAVAGE; LUNG PARENCHYMA; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STAINING; VASCULAR PATENCY;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EMBOLISM, FAT; FIBROSIS; LUNG; PULMONARY EMBOLISM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 73849119556     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20963     Document Type: Article

References (42)

1. Roberts CS, Gleis GE, Seligson D. 2009. Diagnosis and treatment of complications. In: Browner BD, Jupiter JB, Levine AM, et al. editors. Skeletal trauma. 4th ed. Philadelphia: WB Saunders. p 545-588.
2. Paredes S, Comer F, Rubin S, et al. 1965. Distribution of fat tagged with I-131 within the body of the rat at various times following intravenous injection. J Bone Joint Surg [Am] 47: 1216-1220.
3. Schemitsch EH, Bhandari M. 2001. Complications. In: Bucholz RW, Heckman JD, editors. Rockwood and Green's fractures in adults. 5th ed. Philadelphia: Lippincott Williams & Wilkins. p 463-556.
4. El-Ali KM, Gourlay T. 2006. Assessment of the risk of systemic fat mobilization and fat embolism as a consequence of liposuction: ex vivo study. Plast Reconstr Surg 117:2269-2276.
5. Wang HD, Zheng JH, Deng CL, et al. 2008. Fat embolism syndromes following liposuction. Aesthetic Plast Surg 32: 731-736.
6. Dorr LD, Merkel C, Mellman MF, et al. 1989. Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clin Orthop Relat Res 248:112-118.
7. Gelinas JJ, Cherry R, MacDonald SJ. 2000. Fat embolism syndrome after cementless total hip arthroplasty. J Arthroplasty 15:809-813.
8. Syed MI, Jan S, Patel NA, et al. 2006. Fatal fat embolism after vertebroplasty: identification of the high-risk patient. Am J Neuroradiol 27:343-345.
9. Cossman FP, Adler F, Kittle CF, et al. 1960. Lipuria and lipasemia after thoracic surgical procedures. J Thorac Cardiovasc Surg 40:430-442.
10. Peltier LF. 1967. Fat embolism: a pulmonary disease. Surgery 62:756-758.
11. Bulger EM, Smith DG, Maier RV, et al. 1997. Fat embolism syndrome. A 10-year review. Arch Surg 132:435-439.
12. Memtsoudis SG, Rosenberger P, Walz JM. 2007. Critical care issues in the patient after major joint replacement. J Intensive Care Med 22:92-104.
13. Nikolic S, Micic J, Savic S, et al. 2000. Post-traumatic pulmonary and systemic fat embolism in forensic practice. Prospective histological study. Srp Arh Celok Lek 128:90-93.
14. Kao SJ, Yeh DY, Chen HI. 2007. Clinical and pathological features of fat embolism with acute respiratory distress syndrome. Clin Sci (Lond) 113:279-285.
15. Gossling HR, Pellegrini VD Jr. 1982. Fat embolism syndrome: a review of the pathophysiology and physiological basis of treatment. Clin Orthop Relat Res 165:68-82.
16. Robert JH, Hoffmeyer P, Broquet PE, et al. 1993. Fat embolism syndrome. Orthop Rev 22:567-571.
17. Peltier LF. 1988. Fat embolism. A perspective. Clin Orthop Relat Res 232:263-270.
18. Fabian TC. 1993. Unravelling the fat embolism syndrome. N Engl J Med 329:961-963.
19. Armstrong HJ, Kuenzig MC, Peltier LF. 1967. Lung lipase levels in normal rats and rats with experimentally produced fat embolism. Proc Soc Exp Biol Med 124:959-961.
20. Peltier LF. 1956. Fat embolism. III. The toxic properties of neutral fat and free fatty acids. Surgery 40:665-670.
21. Szabo G, Magyar Z, Reffy A. 1977. The role of free fatty acids in pulmonary fat embolism. Injury 8:278-283.
22. Inoue H, Hanagama M, Kamiya M, et al. 2007. Experimental pulmonary fat embolism induced by injection of triolein in rats. Leg Med (Tokyo) 10:26-30.
23. Molteni A, Wolfe LF, Ward WF, et al. 2007. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr Pharm Des 13:1307-1316.
24. Cohen EP, Molteni A, Hill P, et al. 1996. Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab Invest 75:349-360.
25. Molteni A, Moulder JE, Cohen EP, et al. 2001. Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker. Exp Biol Med 226:1016-1023.
26. Kao SJ, Su CF, Liu DD, et al. 2007. Endotoxin-induced acute lung injury and organ dysfunction are attenuated by pentobarbital anaesthesia. Clin Exp Pharmacol Physiol 34:480-487.
27. Boyd HM, Peltier LF, Scott JR, et al. 1956. Fat embolism. II. The chemical composition of fat obtained from human long bones and subcutaneous tissue. Surgery 40:661-664.
28. Peltier LF, Scott JR. 1957. Fat embolism; changes in the level of the blood lipase following the intravenous injection of neutral fat, fatty acids, and other substances into dogs. Surgery 42:541-547.
29. Molteni A, Ward WF, Ts'ao CH, et al. 1984. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc Soc Exp Biol Med 176:88-94.
30. Last JA, Reiser KM. 1989. Biosynthesis of collagen crosslinks. III. In vivo labeling and stability of lung collagen in rats with bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 1:111-117.
31. Ward WF, Molteni A, Solliday NH, et al. 1985. The relationship between endothelial dysfunction and collagen accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 11:1985-1990.
32. Zakheim RM, Mattioli L, Molteni A, et al. 1975. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest 33:57-61.
33. Compton SK, Hamosh M, Hamosh P. 1984. Hydrolysis of neutral lipids and phospholipids in the isolated, perfused rat lung. Biochim Biophys Acta 795:30-36.
34. Gal S, Bassett DJ, Hamosh M, et al. 1982. Triacylglycerol hydrolysis in the isolated, perfused rat lung. Biochim Biophys Acta 713:222-229.
35. Nakata Y, Tanaka H, Kuwagata Y, et al. 1999. Triolein-induced pulmonary embolization and increased microvascular permeability in isolated perfused rat lungs. J Trauma 47:111-119.
36. Nagai H, Kira S, Mimoto T, et al. 1991. Sequential changes of perivascular edema cuffs in models of permeability and hemodynamic pulmonary edema. Respiration 58:57-61.
37. Molteni A, Ward WF, Ts'ao CH, et al. 1985. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc Soc Exp Biol Med 180:112-120.
38. Mancini GB, Khalil N. 2005. Angiotensin II type 1 receptor blocker inhibits pulmonary injury. Clin Invest Med 28:118-126.
39. Ward WF, Molteni A, Ts'ao CH. 1989. Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817. Radiat Res 117:342-350.
40. Baybutt RC, Herndon BL, Umbehr J, et al. 2007. Effects on cytokines and histology by treatment with the ACE inhibitor captopril and the antioxidant retinoic acid in the monocrotaline model of experimentally induced lung fibrosis. Curr Pharm Des 13:1327-1333.
41. Veerappan A, Reid AC, Estephan R, et al. 2008. Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction. Proc Natl Acad Sci USA 105:1315-1320.
42. Adler F, Herndon B, McIff T, et al. 2008. Involvement of the renin-angiotensin system (RAS) in the fibrotic changes induced by fat embolism in the rat. In: Proceedings of the 15th International Colloquium on Lung and Airway Fibrosis, Sunset Beach, NC, p 14.